Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep-Oct;26(5):841-845.
doi: 10.4103/aian.aian_636_23. Epub 2023 Oct 5.

Cranial Nerve Involvement Apart from Optic Nerve in MOG-Antibody Disease: Putative Mechanisms

Y Muralidhar Reddy  1 , Subhendu Parida  1 , Amreen Khan  1 , Abhinay K Gattu  1 , Shyam K Jaiswal  1 , Jagarlapudi M K Murthy  1
Affiliations

Cranial Nerve Involvement Apart from Optic Nerve in MOG-Antibody Disease: Putative Mechanisms

Y Muralidhar Reddy et al. Ann Indian Acad Neurol. 2023 Sep-Oct.
No abstract available

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
T1-weighted contrast MR axial sequences showing cranial nerve enhancement (bold white arrows): cisternal and intra-canalicular segments of bilateral VII-VIII complex (a) and cisternal segment of right V (b); cisternal VII-VIII on left side (c); cisternal segments of bilateral trigeminal (d); FLAIR axial of the brain showing hyperintensities in the medulla, pons, bilateral inferior cerebellar peduncles, left middle cerebellar peduncle, left cerebellum, and periaqueductal gray matter of midbrain (e and f); FLAIR sagittal of the cervical cord showing hyperintensities in central cervical cord up to C3 level (g); FLAIR sagittal of the brain and cervical cord showing cord atrophy and patchy hyperintensities in the pons and cervical cord (h)
Figure 2
Figure 2
Line diagram showing disease course and relapses with episodes involving cranial nerves marked in black
See this image and copyright information in PMC

References

    1. Banwell B, Bennett JL, Marignier R, Kim HJ, Brilot F, Flanagan EP, et al. . Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. Lancet Neurol 2023;22:268–82. - PubMed
    1. Netravathi M, Holla VV, Nalini A, Yadav R, Vengalil S, Oommen AT, et al. . Myelin oligodendrocyte glycoprotein-antibody-associated disorder: A new inflammatory CNS demyelinating disorder. J Neurol 2021;268:1419–33. - PubMed
    1. Cobo-Calvo A, Ayrignac X, Kerschen P, Horellou P, Cotton F, Labauge P, et al. . Cranial nerve involvement in patients with MOG antibody-associated disease. Neurol Neuroimmunol Neuroinflamm 2019;6:e543. doi:10.1212/NXI.0000000000000543. - PMC - PubMed
    1. Du Y, Xiao L, Ding Z, Huang K, Xiao B, Feng L. MOGAD involving cranial neuropathies: A case report and review of literature. Brain Sci 2022;12:1529. doi:10.3390/brainsci12111529. - PMC - PubMed
    1. Razali AM, Zain AM, Din NM, Tan HJ, Ng CF. MOG antibody-associated disease with recurrent optic neuritis and multiple cranial neuropathies: A rare clinical phenotype. Neurol India 2020;68:500–1. - PubMed